Accession Number: | 0000899243-22-023771 |
Date: | 2022-06-22 |
Issuer: | CULLINAN ONCOLOGY, INC. (CGEM) |
Original Submission Date: |
GADICKE ANSBERT
C/O CULLINAN ONCOLOGY, INC.
ONE MAIN STREET, SUITE 520
CAMBRIDGE, MA 02142
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 12.73 | 2022-06-22 | deemed execution date | A | 16,475 (a) | 2032-06-21 | common stock 16,475 | $12.73 | 16,475 | direct |
ID | footnote |
---|---|
f1 | the option represents a right to purchase a total of 16,475 shares of the issuer's common stock, which shall vest in full on the earlier of (i) june 22, 2023 or (ii) the date of the issuer's next annual meeting, subject to the reporting person's continued service as a director on such vesting date. |